AMN Healthcare Services Inc (AMN) stock is surging 7.98% in pre-market trading following the release of its third-quarter 2025 financial results, which significantly exceeded analyst expectations. The healthcare staffing company reported robust performance across its key segments and provided an optimistic outlook for the fourth quarter, fueling investor confidence.

For Q3 2025, AMN Healthcare reported revenue of $634.5 million, surpassing the consensus estimate of $618.1 million. While this represents an 8% year-over-year decline, it still beat market expectations. The company's adjusted earnings per share (EPS) of $0.39 significantly outperformed the analyst forecast of $0.21, although it was down 36% compared to the same quarter last year. Net income for the quarter stood at $29.3 million, with a gross margin of 29.1%. The better-than-expected results were driven by strong performances in the Nurse and Allied Solutions and Physician and Leadership Solutions segments.

Looking ahead, AMN Healthcare has provided a positive outlook for Q4, projecting revenue between $715 million and $730 million. The company expects its Nurse and Allied Solutions revenue to rise 1-3% year-over-year. Additionally, AMN Healthcare reported a rebound in staffing orders and higher winter order volume, suggesting improved demand trends. The company has also enhanced its financial flexibility by refinancing its senior notes and extending its credit facility. These factors, combined with the strong quarterly results, have contributed to the significant pre-market stock price surge, reflecting increased investor optimism about AMN Healthcare's future prospects.